NCT07691411 An Ecological Momentary Assessment Based Program to Support Self-Management for Post-stroke Patients
| NCT ID | NCT07691411 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The Hong Kong Polytechnic University |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2026-01-06 |
| Primary Completion | 2026-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2026-01-06 with a primary completion date of 2026-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this feasibility study is to test whether a new approach that combines real-time symptom tracking (Ecological Momentary Assessment) with machine learning can help people recovering from a stroke to better manage depression, thinking difficulties, and daily functioning. The main questions it aims to answer are: Is this combined approach practical and acceptable for post-stroke survivors? Does the program improve mood, cognitive function, or functional ability to carry out daily activities? Participants will: Use a smartphone app called RehabCare Companion for a period of time Answer brief daily surveys about their mood, thoughts, and activities for one week Receive personalized self-care suggestions generated by machine learning based on their responses Complete assessments of depression, cognition, and functioning before and after the program Take part in a group interview to share their experiences
Eligibility Criteria
Inclusion Criteria: * adults aged 18 years or older * having a confirmed diagnosis of stroke * having sufficient proficiency in Cantonese to understand and respond to the assessments and prompts * having a Hong Kong version of the Montreal Cognitive Assessment (HK-MoCA) score of 18 or higher * having a smartphone. Exclusion Criteria: * they have moderate to severe cognitive impairment (a HK-MoCA score of 17 or lower) * they have active psychiatric disorders other than depression (e.g., schizophrenia, bipolar disorder) * they have a terminal illness or prognosis that suggests a limited life expectancy * they have conditions that compromise their self-care ability (i.e., bedbound).
Contact & Investigator
Arkers KC Wong, PhD
PRINCIPAL INVESTIGATOR
The Hong Kong Polytechnic University
Frequently Asked Questions
Who can join the NCT07691411 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07691411 currently recruiting?
Yes, NCT07691411 is actively recruiting participants. Contact the research team at arkers.wong@polyu.edu.hk for enrollment information.
Where is the NCT07691411 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong.
Who is sponsoring the NCT07691411 clinical trial?
NCT07691411 is sponsored by The Hong Kong Polytechnic University. The principal investigator is Arkers KC Wong, PhD at The Hong Kong Polytechnic University. The trial plans to enroll 50 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.